The U.S. Court of Appeals for the Federal Circuit (CAFC) on Friday affirmed a Patent Trial and Appeal Board (PTAB) decision denying Pfizer’s motions to amend two patent claims. This is Pfizer’s a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results